Preventing, Detecting and Responding to Global Health Threats with Simple and Fast Syndromic Testing Technologies
No invitations necessary; open to all conference registrants
Monday 5 December
8:00 – 12:00
CTICC room location: 2.61-2.63
- Lab Managers
- Lab Technicians
- ED clinicians
Join us for the bioMérieux symposium on “Preventing, Detecting and Responding to Global Health Threats with Simple and Fast Syndromic Testing Technologies”. The symposium includes keynote lectures, talks and panel discussion on how syndromic testing for infectious diseases can lead to better healthcare system in African countries.
The symposium is organized in two parts:
Part 1: Management of Sepsis in Mothers, Children and Neonates: Impact of Simple and Rapid Diagnostic Tools
Part 2: Impact of Rapid Molecular Syndromic Testing : Response to Global Health Threats
Sepsis is the severe failure of certain organs, resulting from an inappropriate immune response in the body’s reaction to an infection. Someone, somewhere around the world, dies of this pathology every three to four seconds, which is more than any cancer. Yet it can be prevented with rapid diagnosis. The first session provides participants an opportunity to learn about how testing for PCT interweaves with other diagnostic modalities for Sepsis and particularly highlights the efforts of bioMérieux in fighting this deadly pathology.
In second part, the focus for infectious disease topics will be on Respiratory Illnesses, Gastrointestinal diseases, Ebola, Meningitis and Encephalitis. The talks will highlight how FilmArray® technology plays a pivotal role in disease diagnosis, surveillance, outbreak investigation, initiation and monitoring of therapy, as well as research into different disease symptoms.
Rapid diagnoses of infectious diseases is needed to reduce maternal and child morbidity and overall mortality rates on the African continent. Healthcare practitioners are often challenged due to lack of tools, resources, or availability of test results in time. This often leads to many patients being undiagnosed and patient conditions unnecessarily worsened by masked infections. Fortunately, many of the top killers are preventable. The FilmArray technology is the fastest and simplest way to a most comprehensive diagnosis of disease causing pathogens with results available in 1 hr. The introduction of this technology will revolutionize African laboratories and their ability to provide accurate and rapid diagnosis of respiratory diseases, gastrointestinal infections, meningitis and encephalitis cases and also respond to global health threats such as Ebola.
You will hear firsthand from laboratories in Africa their experiences of using FilmArray and the practical aspects of implementing such an easy to use technology for routine use within the laboratory with minimal training requirements and virtually no technical competence to run a complex molecular PCR based genetic test.
As a result of attending the symposium, participants will be able to:
- Review clinical best practices and new tools available for rapid diagnosis of disease causing pathogens in pregnant and postpartum women and newborns.
- Reflect on five disease pathologies across the continuum of molecular diagnostics from implementation to care that will impact clinical practice.
- Highlight the utility of FilmArray for patient management, surveillance, outbreak investigation, targeted disease therapy, and reduction of antibiotics.
- Integrate knowledge learned by engaging in dialogue with other health care professionals from a range of disciplines.
- Appreciate the commitment of bioMérieux in responding to the needs of Africa and pioneering diagnostics to provide the best care possible.
For more information please visit us at booth #43 at ASLM2016.
SESSION LEARNING OBJECTIVES:
- Syndromic Approach
Dr. Christine Ginocchio, PhD, MT (ASCP), Hofstra North Shore-LIJ School of Medicine,NY, USA
Dr. Ginocchio is VP, Global Microbiology Affairs, bioMérieux, NC, VP, Scientific and Medical Affairs, BioFire Diagnostics, and Clinical Professor of Medicine, Hofstra North Shore-LIJ School of Medicine, NY. Prior to her current position, she was the Senior Medical Director and Chief, Division of Infectious Disease Diagnostics, Department of Pathology and Laboratory Medicine North Shore-LIJ Health System Laboratories, NY for 21 years and Research Professor, Feinstein Institute for Medical Research, Manhasset, NY. She has 40 years’ experience in all phases of laboratory management and clinical diagnostics, including the management of a large multi-hospital reference Core Laboratory that performed diagnostic testing for 12 regional hospitals, hundreds of physician offices, clinics, and extended care facilities. She has been the principal investigator for more than 60 diagnostic industry and pharmaceutical clinical trials which included 23 studies of in vitro diagnostic devices for US FDA clearance. Dr. Ginocchio’s areas of extra-mural funded research have included HIV, CMV, respiratory viruses, HPV, antibiotic resistance and molecular diagnostics for infectious diseases. Her awards include the President’s Award and Irving Abrahams Award for outstanding basic science research, the PASCV 2012 award in Diagnostic Virology and the ASM 2013 BD Award for Research in Clinical Microbiology. Dr. Ginocchio is a member of the ASM (Delegate, Laboratory Practices Committee), PASCV (President 2012-2014), ASCP, AMP, IDSA (Research Committee [2012-2014] and Diagnostics Task Force [2012-2016]), CLSI (2014-2016), and the CAP (Microbiology Resource Committee 2005-2012). She is Co-Editor-in-Chief for the Journal of Clinical Virology, Section Editor, 10th, 11th and 12th editions of the Manual of Clinical Microbiology, and on the Editorial Board for Clinical Microbiology Reviews. Dr. Ginocchio has published 10 book chapters, over 225 peer-reviewed articles/abstracts and has been an invited speaker at over 200 national and international conferences. She has been a member of National/International Advisory panels for the CDC, NIH, NIAID, FDA, IDSA and European Union. She also currently serves on the JCAHO Influenza Pandemic Preparedness and Response Task Force and the CDC Infectious Disease Laboratory Working Group, Board of Scientific Counselors, Office of Infectious Diseases.
Dr. Yogandhree Govender
Dr David Boulware
Dr. David Boulware is a Distinguished Associate Professor of Medicine at the University of Minnesota (US), who is infectious disease physician-scientist from the with additional formal training in public health, clinical trials, and tropical medicine. As a translational researcher, Dr. Boulware combines his clinical research training with basic science investigations into disease pathogenesis. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved care. Dr. Boulware’s current research is focused on fundamentally improving the clinical outcomes of HIV-infected persons with meningitis. Dr. Boulware has active research collaborations in Uganda, South Africa, Tanzania, and Ethiopia leading a multidisciplinary, international research team.
Dr Zsolt Becze
Dr Francoise Gay-Andrieu